InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Cini John K., Directeur Scientifique. Insider active across 1 companies, notably Sonnet BioTherapeutics Holdings, Inc.. Cumulatively, 3 reports have been logged. The latest transaction was filed on 25 May 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
80,034 shares
Common Stock
SEC:0001493152-22-009484:0·
€17,26314,004 shares@ €1.2327100.0% of flow
Common Stock
SEC:0001493152-21-013205·
€17,26314,004 shares@ €1.232750.0% of flow
Common Stock
SEC:0001493152-21-013205:0·
3 of 3 declarations
About Cini John K.
John K. Cini is the Chief Scientific Officer at Sonnet BioTherapeutics Holdings, Inc. He is responsible for leading the company's research and development initiatives. His scientific expertise is crucial for the development of new therapies and solutions in the biotechnology field.
